To address funding needs for the European CBP501 Phase III trial, CanBas Co., Ltd. has executed a master overdraft facility agreement with SBJ Securities. The maximum borrowing limit is 5 hundred million yen, the interest rate is a fixed 3.0%, and the facility period is 2026-11-02 to 2027-05-07. Individual borrowings will be made as progress dictates.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4575","jir_company_name":"CanBas Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-14","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/4575-20261014-02.pdf","jir_short_summary":"To address funding needs for the European CBP501 Phase III trial, CanBas Co., Ltd. has executed a master overdraft facility agreement with SBJ Securities. The maximum borrowing limit is 5 hundred million yen, the interest rate is a fixed 3.0%, and the facility period is 2026-11-02 to 2027-05-07. Individual borrowings will be made as progress dictates.","jir_summary":"### Expansion of Financing Measures\nCanBas Co., Ltd. has executed a master overdraft facility agreement with SB Securities to meet funding needs for the European Phase III trial. Individual borrowings under this master agreement will be made within the borrowing limit of 5 hundred million yen, taking into account trial progress and funding requirements. If funds are raised using the issuance of stock acquisition rights, the proceeds are planned to be allocated to repayment, and a security reservation agreement is planned to be executed.\n\n### Outlook and Impact\nThe impact on results for the fiscal year ending June 2027 is expected to be minor. Any execution of additional borrowings or other disclosures will be promptly announced.","jir_financial_highlights":"Maximum Borrowing Limit: 5 hundred million yen (Unknown)\nInterest Rate: Fixed interest rate 3.0% (base rate + spread) (Unknown)\nContract Period: 2026-11-02\u301c2027-05-07 (scheduled) (Unknown)","jir_category":"","jir_hashtags":"#CanBasCoLtd avoids using the full formal name in some contexts to protect confidentiality","jir_key_figures":"Maximum Borrowing Limit: 5 hundred million yen\nContract Period: 2026-11-02\u301c2027-05-07\nInterest Rate: Fixed interest rate 3.0%","jir_meta_title":"CanBas Co., Ltd. Executes Framework Financing Agreement with SB Securities | October 2026","jir_meta_description":"CanBas Co., Ltd. has executed a master overdraft facility agreement with SB Securities to secure funding for the European CBP501 Phase III trial. Maximum borrowing limit 5 hundred million yen, interest rate 3.0%, term November 2026\u2013May 2027. Future borrowings will depend on trial progress.","jir_og_title":"CanBas Co., Ltd. Executes Framework Financing Agreement with SB Securities | October 2026","jir_og_description":"To prepare for funding needs related to the European Phase III trial, CanBas Co., Ltd. has signed a master overdraft facility agreement with SB Securities. Borrowing limit 5 hundred million yen, interest rate 3.0%, term from 2026-11-02 to 2027-05-07.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":58229,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"executive_change","footnotes":""},"sector":[],"importance":[],"class_list":["post-130829","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n